9F Inc. ADR buy krebskrebs
Start price
06.04.21
/
50%
€29.40
Target price
06.04.22
€60.00
Performance (%)
-44.56%
End price
07.04.22
€16.30
Summary
This prediction ended on 07.04.22 with a price of €16.30. The BUY prediction by krebskrebs for 9F Inc. ADR performed very badly with a performance of -44.56%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| 9F Inc. ADR | - | - | - | - |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % | 53,20 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % | 91,09 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % | 63,93 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % | 64,84 % |
Comments by krebskrebs for this prediction
In the thread 9f Inc. diskutieren
Buy mit Kursziel 3,0
In the thread Trading 9f Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

